MCE 的所有產品僅用作科學研究或藥證申報，我們不為任何個人用途提供產品和服務。

Tazarotene

CAS No. : 118292-40-3

MCE 國際站：Tazarotene

產品活性：Tazarotene (AGN 190168) 是選擇性視黃酸受體 (RAR) 激動劑，用于研究斑塊狀銀屑病和尋常痤瘡。

研究領域：Metabolic Enzyme/Protease  |  Vitamin D Related/Nuclear Receptor  |  Autophagy

作用靶點：RAR/RXR  |  Autophagy

In Vitro: Tazarotene (AGN 190168), in both gel and cream formulations, has been used both as monotherapy and as an adjuvant therapy. For psoriasis it has been combined with steroids, calcipotriene and phototherapy, and for acne, with antibiotics. Tazarotene (AGN 190168) has been shown to upregulate the tumor suppressor, Tazarotene (AGN 190168) induced gene 3, which is overexpressed in psoriasis and skin cancer. In human epidermal cell cultures, Tazarotene (AGN 190168) suppresses the gene expression of 2 marker proteins, MRP-8 (calgranulin A) and SKALP (skin derived anti-leukoproteinase), highly elevated in psoriatic epidermis.

In Vivo: Topical gel application provides direct delivery of Tazarotene (AGN 190168) into the skin. At 10 hours after a topical application of 0.1% Tazarotene (AGN 190168) gel to the skin of healthy individuals and patients with psoriasis, approximately 4 to 6% of the dose resides in the stratum corneum and 2% of the dose distributed to the viable epidermis and dermis. Tazarotene (AGN 190168) is designed to undergo rapid and complete metabolism to its active metabolite tazarotenic acid. Tazarotenic acid has a short systemic residence time and limited tissue distribution in animals.When topically applied, Tazarotene (AGN 190168) blocks the induction of ornithine decarboxylase (ODC) activity by the tumour promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) in the epidermis of the hairless mouse.

相關產品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Metabolism/Protease Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Autophagy Compound Library  |  Drug Repurposing Compound Library  |  Differentiation Inducing Compound Library  |  Reprogramming Compound Library  |  NMPA-Approved Drug Library  |  FDA Approved & Pharmacopeial Drug Library  |  Transcription Factor-Targeted Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Nuclear Receptor Compound Library  |  Off-patent Drug Library  |  Highly Selective Activators Library  |  Cell Death Library  |  Retinoic acid  |  TTNPB  |  Bexarotene  |  BMS493  |  AR7  |  Isotretinoin  |  AGN 193109  |  AM580  |  Tamibarotene  |  Talarozole  |  Fenretinide  |  LG100268  |  Magnolol  |  9-cis-Retinoic acid  |  UVI 3003  |  CD437  |  Adapalene  |  AGN 194310  |  CD3254  |  Trifarotene  |  HX531  |  Ch55  |  BMS453  |  Oxybenzone  |  Palovarotene  |  LY2955303  |  Peretinoin  |  AGN-195183  |  Acitretin  |  CD1530

熱門產品線：重組蛋白  |  化合物庫  |  天然產物  |  熒光染料  |  PROTAC  |  同位素標記物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds